Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation
Open Access
- 28 September 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (45) , 73525-73540
Abstract
Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activationKeywords
This publication has 55 references indexed in Scilit:
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff OptimizationPLOS ONE, 2012
- The inositol 5-phosphatase SHIP2 is an effector of RhoA and is involved in cell polarity and migrationMolecular Biology of the Cell, 2012
- Targeting the EGFR signaling pathway in cancer therapyExpert Opinion on Therapeutic Targets, 2012
- Oncogene addiction as a foundational rationale for targeted anti‐cancer therapy: promises and perilsEMBO Molecular Medicine, 2011
- Decreased Expression and Androgen Regulation of the Tumor Suppressor Gene INPP4B in Prostate CancerCancer Research, 2011
- Modeling Oncogenic Signaling in Colon Tumors by Multidirectional Analyses of Microarray Data Directed for Maximization of Analytical ReliabilityPLOS ONE, 2010
- Targeting the PI3K signaling pathway in cancerCurrent Opinion in Genetics & Development, 2010
- Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trialThe Lancet Oncology, 2010
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal CancerNew England Journal of Medicine, 2009
- Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancerGenome Biology, 2007